In the article entitled, “Next-Generation Assessment of Human Growth Factor Receptor 2 (ERBB2) Amplification Status Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay” (Volume 19, pages 244–254 of the March 2017 issue of The Journal of Molecular Diagnostics; http://dx.doi.org/10.1016/j.jmoldx.2016.09.010), the title contained an error that was inadvertently introduced by the editorial office during the proof process. The correct title is “Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay”. This correction is being implemented online ahead of the announcement appearing in print.
. 2017 May;19(3):485. doi: 10.1016/j.jmoldx.2017.02.001
Correction
© 2017 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.
PMCID: PMC6593245 PMID: 28222274
This corrects the article "Next-Generation Assessment of Human Epithelial Growth Factor Receptor 2 (ERBB2) Amplification Status" on page 244.